Biofrontera Inc. License Agreements
6 Contracts & Agreements
- Second Amended and Restated License and Supply Agreement, dated February 19, 2024, between the Company, Pharma and Bioscience (Filed With SEC on February 20, 2024)
- Amended and Restated Addendum to Amended and Restated License and Supply Agreement, dated January 29, 2024 (Filed With SEC on February 2, 2024)
- Addendum to Amended and Restated License and Supply Agreement, dated as of December 12, 2023 (Filed With SEC on December 15, 2023)
- Corrected Amendment to Amended and Restated License and Supply Agreement dated October 8, 2021 by and among Biofrontera Pharma GmbH, Biofrontera Bioscience GmbH and Biofrontera Inc (Filed With SEC on October 13, 2021)
- Amendment to Amended and Restated License and Supply Agreement dated October 8, 2021 by and among Biofrontera Pharma GmbH, Biofrontera Bioscience GmbH and Biofrontera Inc (Filed With SEC on October 12, 2021)
- Amended and Restated License and Supply Agreement dated June 16, 2021 by and among Biofrontera Pharma GmbH, Biofrontera Bioscience GmbH and Biofrontera Inc (Filed With SEC on July 6, 2021)